This result is consistent with a previous study that found that the methylation of GPX3 promoter was more frequent in ESCC tumor tissues (71.4%) than in adjacent nontumor tissues (10.7%) [44]. This evidence concerns the gene GPX3 and esophageal squamous cell carcinoma.